9-136443891-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014866.2(SEC16A):c.6937G>A(p.Asp2313Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000162 in 1,609,196 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014866.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SEC16A | NM_014866.2 | c.6937G>A | p.Asp2313Asn | missense_variant | 31/32 | ENST00000684901.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SEC16A | ENST00000684901.1 | c.6937G>A | p.Asp2313Asn | missense_variant | 31/32 | NM_014866.2 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152098Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000455 AC: 11AN: 241720Hom.: 0 AF XY: 0.0000379 AC XY: 5AN XY: 131770
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1456980Hom.: 0 Cov.: 30 AF XY: 0.0000166 AC XY: 12AN XY: 724748
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74430
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 29, 2024 | The c.6937G>A (p.D2313N) alteration is located in exon 31 (coding exon 29) of the SEC16A gene. This alteration results from a G to A substitution at nucleotide position 6937, causing the aspartic acid (D) at amino acid position 2313 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at